Repeatability of diffusion-weighted imaging in rectal cancer

Journal of Magnetic Resonance Imaging

Volumn 40, Issue 1, 2014, Pages 146-150

  Intven, Martijn ^a   Reerink, Onne ^a   Philippens, Marielle E P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

apparent diffusion coefficient; diffusion weighted MRI; rectal cancer; repeatability

Indexed keywords

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MALE; MEASUREMENT REPEATABILITY; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; RECTUM SURGERY; TREATMENT RESPONSE; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PROCEDURES; RECTAL NEOPLASMS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; OBSERVER VARIATION; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84902369078     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24337     Document Type: Article

References (24)

1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
2. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
3. MacFarlane JK, Ryall RD, Heald RJ,. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-460.
4. Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240: 711-718.
5. Habr-Gama A, Perez RO,. Non-operative management of rectal cancer after neoadjuvant chemoradiation. Br J Surg 2009; 96: 125-127.
6. Bujko K, Kepka L, Nowacki MP,. Chemoradiotherapy alone for rectal cancer: a word of caution. Lancet Oncol 2007; 8: 860-862.
7. Bujko K, Richter P, Kolodziejczyk M, et al. Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders. Radiother Oncol 2009; 92: 195-201.
8. O'Neill BD, Brown G, Heald RJ, et al. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007; 8: 625-633.
9. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011; 18: 2224-2231.
10. Lambrecht M, Vandecaveye V, De Keyzer F, et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys 2012; 82: 863-870.
11. Kim SH, Lee JY, Lee JM, et al. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol 2011; 21: 987-995.
12. Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254: 170-178.
13. Intven M, Reerink O, Philippens ME,. Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy. Strahlenther Onkol 2013; 189: 117-122.
14. Kwee TC, Takahara T, Ochiai R, et al. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008; 18: 1937-1952.
15. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-125.
16. Kim SH, Lee JY, Lee JM, et al. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol 2011; 21: 987-995.
17. Barbaro B, Vitale R, Valentini V, et al. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012; 83: 594-599.
18. Bol GH, Kotte AN, van der Heide UA, et al. Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed 2009; 96: 133-140.
19. Bland JM, Altman DG,. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-160.
20. Braithwaite AC, Dale BM, Boll DT, et al. Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology 2009; 250: 459-465.
21. Rosenkrantz AB, Oei M, Babb JS, et al. Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 tesla. J Magn Reson Imaging 2011; 33: 128-135.
22. Le Bihan D, Poupon C, Amadon A, et al. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 2006; 24: 478-488.
23. Beets-Tan RG, Beets GL,. Local staging of rectal cancer: a review of imaging. J Magn Reson Imaging 2011; 33: 1012-1019.
24. Gibbs P, Pickles MD, Turnbull LW,. Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T. Magn Reson Imaging 2007; 25: 1423-1429.